Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 810 | 426 | 363 | 120 | 73 |
| Cost of Goods | 76 | 41 | 356 | 17 | 23 |
| Gross Profit | 734 | 385 | 6 | 103 | 50 |
| Operating Expenses | 4,891 | 5,095 | 4,189 | 3,535 | 3,746 |
| Operating Income | -4,080 | -4,669 | -3,826 | -3,415 | -3,673 |
| Other Income | 723 | 291 | 175 | 182 | 183 |
| Pre-tax Income | -3,357 | -4,378 | -3,651 | -3,233 | -3,490 |
| Net Income Continuous | -3,357 | -4,378 | -3,651 | -3,233 | -3,490 |
| Net Income | $-3,357 | $-4,378 | $-3,651 | $-3,233 | $-3,490 |
| EPS Basic Total Ops | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 |
| EPS Basic Continuous Ops | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 |
| EPS Diluted Total Ops | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 |
| EPS Diluted Continuous Ops | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 |
| EBITDA(a) | $-3,994 | $-4,598 | $-3,763 | $-3,358 | $-3,620 |